{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["20(2)"],"submitter":["Harmooshi NN"],"pubmed_abstract":["We sought to evaluate the effetc of metformin on body mass index (BMI) and metabolic parameters in HIV-positive patients. We performed a comprehensive search through five major indexing databases, using keywords (\"metformin\" OR \"dimethylguanylguanidine\" OR \"biguanide\" OR<i> \"</i>Glucophage\") AND (\"HIV\" OR \"human immunodeficiency virus\" OR \"AIDS\" OR \"Acquired immunodeficiency syndrome\"), and all possible combinations until January 15, 2021. We measured standardized mean differences (SMD) and 95% confidence intervals (CI) for each outcome. We finally included 12 RCTs (577 participants, 274 in the metformin group and 303 in the comparators). Metformin did not significantly change BMI index compared to various comparators. Metformin generally improve LDL levels (SMD = 0.29, 95% CI: - 1.00 1.57"],"journal":["Journal of diabetes and metabolic disorders"],"pagination":["1901-1911"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8630165"],"repository":["biostudies-literature"],"pubmed_title":["The effect of metformin on body mass index and metabolic parameters in non-diabetic HIV-positive patients: a meta-analysis."],"pmcid":["PMC8630165"],"pubmed_authors":["Harmooshi NN","Zakerkish M","Abeshtan A","Mirmomeni G","Rahim F"],"additional_accession":[]},"is_claimable":false,"name":"The effect of metformin on body mass index and metabolic parameters in non-diabetic HIV-positive patients: a meta-analysis.","description":"We sought to evaluate the effetc of metformin on body mass index (BMI) and metabolic parameters in HIV-positive patients. We performed a comprehensive search through five major indexing databases, using keywords (\"metformin\" OR \"dimethylguanylguanidine\" OR \"biguanide\" OR<i> \"</i>Glucophage\") AND (\"HIV\" OR \"human immunodeficiency virus\" OR \"AIDS\" OR \"Acquired immunodeficiency syndrome\"), and all possible combinations until January 15, 2021. We measured standardized mean differences (SMD) and 95% confidence intervals (CI) for each outcome. We finally included 12 RCTs (577 participants, 274 in the metformin group and 303 in the comparators). Metformin did not significantly change BMI index compared to various comparators. Metformin generally improve LDL levels (SMD = 0.29, 95% CI: - 1.00 1.57","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Dec","modification":"2025-04-26T16:29:27.187Z","creation":"2025-04-06T15:13:58.606Z"},"accession":"S-EPMC8630165","cross_references":{"pubmed":["34900832"],"doi":["10.1007/s40200-021-00869-1"]}}